Page 3 - HFA_Dateline_2019_Q1_Spring_SpecialEdition
P. 3
IN THIS ISSUE:
4Executive Corner. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Show Your Support For HFA:
Between membership and fundraising events, HFA offers
5a number of ways to support its programs and services. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A Look at the U.S. Food and Drug Administration’s
Drug Approval Process: Clinical trials, drug application reviews and
6assessing risk are all part of bringing new products to patients . . . . . . . . . . . . . . . . . . . . . .
Ever-changing Landscape of Products on the Market:
There is no shortage of products on the market. Learn about recent changes
8and see a full list of currently-available products. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fast-moving Changes:
10A helpful chart of the products released in the last seven years. . . . . . . . . . . . . . . . . . . . .
A Complete List of Current Products per
11Bleeding Disorder Indication. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22Snapshot Glossary of Terms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Speaking a Whole New Language:
26Emerging Therapies Terminology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
40Challenges in Access to Care. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
42Understanding Informed Consent. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
44Learn About Clinical Studies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Special Issue 2018-19 | Dateline Federation 3
